Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedThe Study Record History now shows the latest revision as v3.6.5, replacing the previous v3.6.4. This reflects a page revision update at the system level rather than a change to trial details.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision entry v3.6.4 was added to the Record History, reflecting an updated version of the study record. The previous revision v3.6.3 remains in history as a past version.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedThe record history now shows a new revision entry (v3.6.3) replacing the previous one (v3.6.2), updating the page's version state in the history log.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the page, indicating a minor software version update. This change is an internal platform update and does not modify the study data or its history.SummaryDifference0.1%

- Check60 days agoChange DetectedThe history shows the recruitment status changed to 'No longer looking for participants,' indicating enrollment has ended or is paused. A new version tag 'Revision: v3.6.0' appears, while the previous 'Revision: v3.5.5' is removed.SummaryDifference0.4%

- Check67 days agoChange DetectedThe page history shows a new release identifier (v3.5.5) replacing the previous v3.5.4. This indicates a site-level update to the interface.SummaryDifference0.1%

Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.